Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Inactivated Split-Virion Swine-Origin A/H1N1 Influenza Vaccine Without Adjuvant in Healthy Adults
2010-018991-25Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of swine-origin a/h1n1 influenza vaccine in influenza A virus infection (H1N1), sponsored by Sanofi. Primary endpoint: Immunogenicity. Started Feb 2010; status: completed.
02
Drugs
swine-origin a/h1n1 influenza vaccine
03
Conditions
influenza A virus infection (H1N1)
Beyond the preview
Go deeper on 2010-018991-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018991-25.